Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q2

7459.TEDINET S100PLGZ
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥1.69T2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.64T2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥25.5bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥24.3bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥33.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥33.6bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥33.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥34.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥17.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥18.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥21.9bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥23.8bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥1.74Tat 2022-09-30Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.72Tat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.06Tat 2022-09-30Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥674.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥657.2bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥221.2bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥238.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥260.4bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥239.6bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥240.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥9.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥61.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥24.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥5.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥24.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥16.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥82.512022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥43.132022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.232021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥43.252021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥77.562022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥82.792021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio31.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥2.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥2.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30¥191m
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥36.8bn
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥36.8bn
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.4bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥554.9bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥554.7bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥174m
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.0bn
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.10T
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.09T
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1.8bn
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.69T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.69T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥2.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥25.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥1.9bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥1.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30¥304m
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥35.9bn
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥35.9bn
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1m
jpcrp040300-q2r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥531.6bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥531.4bn
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥175m
jpcrp040300-q2r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥13.3bn
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.08T
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.08T
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1.7bn
jpcrp040300-q2r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥9.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.65T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.64T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥24.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Other caCurrentQuarterInstant80293000000JPY
Allowance for doubtful accounts caPrior1YearInstant-1505000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-2130000000JPY
Current assetsPrior1YearInstant1209766000000JPY
Current assetsCurrentQuarterInstant1218421000000JPY
Buildings and structures netPrior1YearInstant96774000000JPY
Buildings and structures netCurrentQuarterInstant104941000000JPY
LandPrior1YearInstant121439000000JPY
LandCurrentQuarterInstant121338000000JPY
Other net ppePrior1YearInstant46160000000JPY
Other net ppeCurrentQuarterInstant40554000000JPY
Property plant and equipmentPrior1YearInstant264374000000JPY
Property plant and equipmentCurrentQuarterInstant266835000000JPY
Other iaPrior1YearInstant9971000000JPY
Other iaCurrentQuarterInstant9639000000JPY
Intangible assetsPrior1YearInstant9971000000JPY
Intangible assetsCurrentQuarterInstant9639000000JPY
Investment securitiesPrior1YearInstant190773000000JPY
Investment securitiesCurrentQuarterInstant200690000000JPY
Other ioaPrior1YearInstant35344000000JPY
Other ioaCurrentQuarterInstant40397000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-757000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-703000000JPY
Investments and other assetsPrior1YearInstant225361000000JPY
Investments and other assetsCurrentQuarterInstant240384000000JPY
Noncurrent assetsPrior1YearInstant499707000000JPY
Noncurrent assetsCurrentQuarterInstant516858000000JPY
AssetsPrior1YearInstant1709474000000JPY
AssetsCurrentQuarterInstant1735280000000JPY
Notes and accounts payable tradePrior1YearInstant907997000000JPY
Notes and accounts payable tradeCurrentQuarterInstant905375000000JPY
Current portion of bonds with subscription rights to sharesPrior1YearInstant30078000000JPY
Current portion of bonds with subscription rights to sharesCurrentQuarterInstant30002000000JPY
Income taxes payablePrior1YearInstant14059000000JPY
Income taxes payableCurrentQuarterInstant14792000000JPY
Provision for bonusesPrior1YearInstant6822000000JPY
Provision for bonusesCurrentQuarterInstant6764000000JPY
Provision for loss on disaster clPrior1YearInstant497000000JPY
Provision for loss on disaster clCurrentQuarterInstant92000000JPY
Provision for loss on anti monopoly act clPrior1YearInstant3479000000JPY
Provision for loss on anti monopoly act clCurrentQuarterInstant3479000000JPY
Other clPrior1YearInstant45881000000JPY
Other clCurrentQuarterInstant45422000000JPY
Current liabilitiesPrior1YearInstant1008816000000JPY
Current liabilitiesCurrentQuarterInstant1005928000000JPY
Net defined benefit liabilityPrior1YearInstant16401000000JPY
Net defined benefit liabilityCurrentQuarterInstant16507000000JPY
Other nclPrior1YearInstant35166000000JPY
Other nclCurrentQuarterInstant38099000000JPY
Noncurrent liabilitiesPrior1YearInstant51568000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass